UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 761

Sortiert nach

Diffuse Glioma Heterogeneity and Its Therapeutic Implications

Cancer discovery, 2021-03, Vol.11 (3), p.575-590

2021

Link zum Volltext

Verfügbarkeit prüfen

Glioblastoma: Not Just Another Cancer

Cancer discovery, 2024-04, Vol.14 (4), p.648

Fine, Howard A

2024

Link zum Volltext

Verfügbarkeit prüfen

Nuclear condensates in YAP1-driven ependymoma

Nature cell biology, 2023-02, Vol.25 (2), p.211

2023

Link zum Volltext

Verfügbarkeit prüfen

New strategies in glioblastoma: exploiting the new biology

Clinical cancer research, 2015-05, Vol.21 (9), p.1984-1988

Fine, Howard A

2015

Link zum Volltext

Verfügbarkeit prüfen

Modeling Patient-Derived Glioblastoma with Cerebral Organoids

Cell reports (Cambridge), 2019-03, Vol.26 (12), p.3203-3211.e5

2019

Link zum Volltext

Verfügbarkeit prüfen

Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate

Proceedings of the National Academy of Sciences - PNAS, 2021-02, Vol.118 (8), p.1

2021

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab in Glioblastoma — Still Much to Learn

The New England journal of medicine, 2014-02, Vol.370 (8), p.764-765

Fine, Howard A

2014

Link zum Volltext

Verfügbarkeit prüfen

SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma

Cell stem cell, 2009-05, Vol.4 (5), p.440-452

2009

Link zum Volltext

Verfügbarkeit prüfen

Shifting the landscape: The role of IDH inhibitors in glioma cell fate

Cancer cell, 2024-05, Vol.42 (5), p.741-743

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date

Cancer, 2015-02, Vol.121 (4), p.502-516

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma

International journal of radiation oncology, biology, physics, 2015-08, Vol.92 (5), p.986-992

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

Journal of clinical oncology, 2009-02, Vol.27 (5), p.740-745

2009

Link zum Volltext

Verfügbarkeit prüfen

Integration and analysis of genome-scale data from gliomas

Nature reviews. Neurology, 2011-08, Vol.7 (8), p.439

2011

Link zum Volltext

Verfügbarkeit prüfen

Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not

Journal of clinical oncology, 2023-02, Vol.41 (6), p.1183-1188

2023

Link zum Volltext

Verfügbarkeit prüfen

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

Journal of immunotherapy (1997), 2019-05, Vol.42 (4), p.126

2019

Link zum Volltext

Verfügbarkeit prüfen

Rembrandt: helping personalized medicine become a reality through integrative translational research

Molecular cancer research, 2009-02, Vol.7 (2), p.157-167

2009

Link zum Volltext

Verfügbarkeit prüfen

Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels

PloS one, 2013-04, Vol.8 (4), p.e62982-e62982

2013

Link zum Volltext

Verfügbarkeit prüfen

Optic nerve activity promotes the growth of optic pathway gliomas: Shedding light on the glioma microenvironment

Cancer cell, 2021-08, Vol.39 (8), p.1056-1058

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Associations between microRNAs and Gene Expression in Glioma Biology

PloS one, 2011-02, Vol.6 (2), p.e14681-e14681

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

Journal of clinical oncology, 2010-03, Vol.28 (7), p.1168-1174

2010

Link zum Volltext

Verfügbarkeit prüfen

Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization

PloS one, 2012-12, Vol.7 (12), p.e51407

2012

Link zum Volltext

Verfügbarkeit prüfen

Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas

Cancer discovery, 2020-07, Vol.10 (7), p.964-979

2020

Link zum Volltext

Verfügbarkeit prüfen

Predicting in vitro drug sensitivity using Random Forests

Bioinformatics, 2011-01, Vol.27 (2), p.220-224

2011

Link zum Volltext

Verfügbarkeit prüfen

Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy

Glia, 2011-08, Vol.59 (8), p.1148-1154

2011

Link zum Volltext

Verfügbarkeit prüfen

The REMBRANDT study, a large collection of genomic data from brain cancer patients

Scientific data, 2018-08, Vol.5 (1), p.180158-180158, Article 180158

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 761

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(593)
Mit Volltextzugriff
(598)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Diffuse Glioma Heterogeneity and Its Therapeutic Implications

Glioblastoma: Not Just Another Cancer

Nuclear condensates in YAP1-driven ependymoma

New strategies in glioblastoma: exploiting the new biology

Modeling Patient-Derived Glioblastoma with Cerebral Organoids

Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate

Bevacizumab in Glioblastoma — Still Much to Learn

SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma

Shifting the landscape: The role of IDH inhibitors in glioma cell fate

Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date

A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma

Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

Integration and analysis of genome-scale data from gliomas

Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

Rembrandt: helping personalized medicine become a reality through integrative translational research

Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels

Optic nerve activity promotes the growth of optic pathway gliomas: Shedding light on the glioma microenvironment

Prediction of Associations between microRNAs and Gene Expression in Glioma Biology

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization

Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas

Predicting in vitro drug sensitivity using Random Forests

Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy

The REMBRANDT study, a large collection of genomic data from brain cancer patients

Suchergebnisse filtern